Botulinum toxin injections for hidradenitis suppurativa
Treatments studied
Part of Infections, Skin clinical trials.
This study tests whether botulinum toxin (Botox) injections can improve hidradenitis suppurativa (a painful skin condition with lumps and abscesses). It may be an option for people who have not improved with antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 13 and 75 years old
- You have had hidradenitis suppurativa (a skin condition with painful lumps or abscesses) for at least 1 year
- You have hidradenitis suppurativa lesions in at least two different body areas
- You have had at least 5 abscesses or nodules (lumps) at the start of the study
- You have had an inadequate response to antibiotics or symptoms returned after stopping antibiotics
- You do not have more than 20 draining tunnels (open channels in the skin)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of an injection (anti-IL-17A/F monoclonal antibody) and a special laser treatment for hidradenitis suppurativa (HS), a painful skin condition with recurring lumps and abscesses. You'll be followed closely to see if this combination helps reduce your symptoms and improves your skin.
This study tests a drug called secukinumab (a type of biologic that targets inflammation) for people with moderate to severe hidradenitis suppurativa (HS). It may be an option if you have tried other treatments and they didn't work well.
This trial tests a new medication called CIT-013 for people with moderate to severe hidradenitis suppurativa (HS) who have not had enough relief from oral antibiotics. The goal is to see if this treatment can reduce painful bumps and abscesses.
This trial tests an investigational medicine, SPY072, for adults with moderate to severe hidradenitis suppurativa (also known as HS), a skin condition that causes painful lumps and sores. If you join, you'll help see if this treatment is safe and effective.
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
This trial tests a 1726-nm laser to reduce inflamed nodules in people with mild to moderate hidradenitis suppurativa (HS). It compares treated and untreated areas to see if the laser helps without affecting the rest of the body.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.